1. Home
  2. RYTM vs FRO Comparison

RYTM vs FRO Comparison

Compare RYTM & FRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • FRO
  • Stock Information
  • Founded
  • RYTM 2008
  • FRO 1985
  • Country
  • RYTM United States
  • FRO Cyprus
  • Employees
  • RYTM N/A
  • FRO N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • FRO Marine Transportation
  • Sector
  • RYTM Health Care
  • FRO Consumer Discretionary
  • Exchange
  • RYTM Nasdaq
  • FRO Nasdaq
  • Market Cap
  • RYTM 3.2B
  • FRO 3.6B
  • IPO Year
  • RYTM 2017
  • FRO N/A
  • Fundamental
  • Price
  • RYTM $52.70
  • FRO $14.88
  • Analyst Decision
  • RYTM Strong Buy
  • FRO Strong Buy
  • Analyst Count
  • RYTM 12
  • FRO 3
  • Target Price
  • RYTM $68.58
  • FRO $27.33
  • AVG Volume (30 Days)
  • RYTM 544.5K
  • FRO 3.2M
  • Earning Date
  • RYTM 05-06-2025
  • FRO 02-28-2025
  • Dividend Yield
  • RYTM N/A
  • FRO 11.89%
  • EPS Growth
  • RYTM N/A
  • FRO N/A
  • EPS
  • RYTM N/A
  • FRO 2.23
  • Revenue
  • RYTM $130,126,000.00
  • FRO $2,050,385,000.00
  • Revenue This Year
  • RYTM $47.06
  • FRO N/A
  • Revenue Next Year
  • RYTM $68.10
  • FRO $13.34
  • P/E Ratio
  • RYTM N/A
  • FRO $6.72
  • Revenue Growth
  • RYTM 68.06
  • FRO 13.77
  • 52 Week Low
  • RYTM $35.17
  • FRO $13.17
  • 52 Week High
  • RYTM $68.58
  • FRO $29.39
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 48.00
  • FRO 39.89
  • Support Level
  • RYTM $52.54
  • FRO $15.72
  • Resistance Level
  • RYTM $55.21
  • FRO $16.57
  • Average True Range (ATR)
  • RYTM 2.05
  • FRO 0.47
  • MACD
  • RYTM 0.36
  • FRO -0.07
  • Stochastic Oscillator
  • RYTM 47.82
  • FRO 12.63

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About FRO Frontline Plc

Frontline PLC is an international shipping company engaged in the seaborne transportation of crude oil and oil products. Group operates through the tankers segment. The tankers segment includes crude oil tankers and product tankers. Its geographical area of operation includes Arabian Gulf, West African, the North Sea, and the Caribbean. Frontline earns revenue through voyage charters, time charters, and a finance lease. It is also involved in the charter, purchase, and sale of vessels.

Share on Social Networks: